KR101631657B1 - Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof - Google Patents

Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof Download PDF

Info

Publication number
KR101631657B1
KR101631657B1 KR1020150010809A KR20150010809A KR101631657B1 KR 101631657 B1 KR101631657 B1 KR 101631657B1 KR 1020150010809 A KR1020150010809 A KR 1020150010809A KR 20150010809 A KR20150010809 A KR 20150010809A KR 101631657 B1 KR101631657 B1 KR 101631657B1
Authority
KR
South Korea
Prior art keywords
overtransferrin
hydrolyzate
present
tcep
transferrin
Prior art date
Application number
KR1020150010809A
Other languages
Korean (ko)
Other versions
KR20150024362A (en
Inventor
백현동
안동욱
박은주
문선희
이재훈
이경아
민근영
Original Assignee
건국대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 건국대학교 산학협력단 filed Critical 건국대학교 산학협력단
Priority to KR1020150010809A priority Critical patent/KR101631657B1/en
Publication of KR20150024362A publication Critical patent/KR20150024362A/en
Application granted granted Critical
Publication of KR101631657B1 publication Critical patent/KR101631657B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/30Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/04Animal proteins
    • A23L1/305
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은 난백 단백질인 오버트랜스페린을 TECP로 가수분해하여 기능성 펩타이드를 제조하여 항산화 기능이 증대된 오버트랜스페린의 가수분해물을 제공하는 뛰어난 효과가 있다. The present invention has an excellent effect of providing a hydrolyzate of overtransferrin having an increased antioxidant function by preparing a functional peptide by hydrolyzing an over-transferrin, an egg white protein, with TECP.

Description

항산화 활성을 갖는 난백 단백질 오버트랜스페린의 가수분해물 및 그 제조방법 {Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof}TECHNICAL FIELD The present invention relates to a hydrolyzate of an ovarian protein overtransferrin having an antioxidant activity and an antioxidant activity and a method for preparing the same,

본 발명은 오버트랜스페린이 포함하고 있는 15개의 이황화 결합 부위를 선택적으로 절단하는 Tris(2-carboxyethyl) phosphine hydrochloride (TCEP)를 통해서 상기 오버트랜스페린의 이황화 결합을 절단하여 기능성 오버트랜스페린 가수분해물을 제조하고 그 가수분해물을 유효성분으로 하는 항산화 소재개발에 관한 것이다.The present invention relates to a method for producing a functional overtransferrin hydrolyzate by cleaving a disulfide bond of the overtransferrin through Tris (2-carboxyethyl) phosphine hydrochloride (TCEP) which selectively cleaves 15 disulfide bond sites contained in overtransferrin, And to the development of antioxidative materials containing the hydrolyzate as an active ingredient.

항산화란 물질의 산화를 억제하는 성질로 식품계에서는 산화에 의해 일어나는 식품의 풍미와 색의 변화, 유지의 산패 등을 방지하거나 지연하는 기능을 말한다. 상기의 산화를 억제하는 기능은 식품계 뿐만 아니라 생체 내에서도 활성산소로 인해 발생하는 암이나, 동맥경화, 당뇨병과 같은 질병을 예방할 수 있어 항산화제에 대한 관심이 고조되고 있다(손 등, 식품과학과 산업, 30:22-29, 1997). Antioxidant is a property that inhibits the oxidation of a substance. In the food system, it refers to a function of preventing or delaying changes in flavor and color of food caused by oxidation, rancidity of the oil, and the like. The above-mentioned function of inhibiting the oxidation can be prevented not only in the food system but also in the living body, such as cancer caused by active oxygen, atherosclerosis and diseases such as diabetes, , 30: 22-29, 1997).

일반적으로 현재 사용하고 있는 항산화제는 합성 항산화제와 천연 항산화제로 구분되는데, 대표적인 합성 항산화제인 butylated hydroxytoluene (BHT)은 동물실험에서 기형 발생 또는 암 발생에 관여하는 것으로 보고되고 있어(Branen et al., Amer. Oil Chem. Soc., 52;59-63, 1975) 뛰어난 항산화 효과에 반해 그로 인한 부작용 역시 문제시되고 있다. 반면 천연 항산화제는 합성 항산화제와 비교했을 때 부작용이 거의 없어 식품첨가물 또는 약품으로 현재 α-tocopherol이 사용되고 있지만, 비싼 가격과 지용성이라는 이용 상의 제약으로 인해 대체 천연 항산화제의 개발이 요구되고 있는 실정이기에 이에 관한 연구가 활발히 이루어지고 있다(Lee et al., Korean J. Food Preserv., 11;126-129, 2004, Lee et al., J. Life Sci., 18;1106-1114, 2008).
In general, the currently used antioxidants are classified into synthetic antioxidants and natural antioxidants. Butylated hydroxytoluene (BHT), a representative synthetic antioxidant, has been reported to be involved in teratogenesis or cancer development in animal experiments (Branen et al. Amer. Oil Chem. Soc., 52; 59-63, 1975). In addition to its excellent antioxidant effect, the side effects are also questionable. On the other hand, natural antioxidants are currently used as food additives or medicines because they have few side effects when compared with synthetic antioxidants. However, the development of alternative natural antioxidants is required due to limitations on the use of expensive and fat- Lee et al., J. Life Sci., 18, 1106-1114, 2008). In addition, there are many studies that have been conducted in Korea.

천연의 완전식품으로 잘 알려진 계란은 각 성분들의 생리적 기능과 상호작용에 의한 역할이 밝혀지고 있고, 기능성 건강식품의 주요한 소재로 사용될 수 있다는 점에서 그 중요성이 더욱 강조되고 있다(Jeon et al., J. Food Sci. Ani. Resour.,22;267-273, 2002). 달걀의 철 결합 단백질인 오버트랜스페린은 albumin 다음으로 많은 비중을 차지하는 단일체 당단백질로서 한 분자 당 15개의 이황화 결합을 갖고 있으며, 2개의 철 이온과 결합할 수 있는 능력을 지닌 transferrin의 일종이다 (Wu and Acero-Lopez, Food Res. Int., 46;480-487, 2012). 이와 같이 철 원자에 대한 높은 결합력을 가져 미생물 성장에 필수 영양 성분인 철을 결합하여 제거함으로써 항균력을 가지는 것으로 알려져 있고(Ibrahim. et al., Bioch. Biophys. Acta., 1523;196-205, 2000) 그 외에도 항암(Ibrahim and Kiyono, J. Agric. Chem. 57;11383-11390, 2009), 면역증강(Hirota et al., J. Vet. Med. Sci., 57;825-829, 1995), 항 고혈압(Lee et al., J. Food Sci. Ani. Resour., 30;286-290, 2010) 등의 생리활성이 알려져 있다.
Eggs, well known as natural complete foods, have been shown to play a role in the physiological functions and interactions of the components, and their importance is being emphasized in that they can be used as a major ingredient in functional health foods (Jeon et al. J. Food Sci. Ani Resour., 22: 267-273, 2002). Over-transferrin, an iron-binding protein in eggs, is a monosaccharide protein that occupies a heavier weight next to albumin. It has 15 disulfide bonds per molecule and is a kind of transferrin capable of binding two iron ions (Wu and Acero-Lopez, Food Res. Int., 46: 480-487, 2012). In this way, it has been known that iron has high binding capacity to iron atoms, and thus has an antibacterial activity by binding and removing iron, an essential nutrient for microbial growth (Ibrahim et al., Bioch. Biophys. Acta., 1523, 196-205, 2000 In addition, anti-cancer (Ibrahim and Kiyono, J. Agric. Chem. 57: 11383-11390, 2009), immune enhancement (Hirota et al., J. Vet. Med. Sci., 57: 825-829, The physiological activities such as anti-hypertension (Lee et al., J. Food Sci., Ani. Res. 30, 286-290, 2010) are known.

식품 단백질은 인체 내에서 소화 혹은 식품 제조 과정 중의 발효, 숙성 과정 중 변성을 일으키고 이는 생체 내에서 다양한 생리활성을 나타낼 수 있다고 알려져 있다(Moller et al., 2008). 따라서 단백질뿐만 화학적 물리적 변성이 일어난 단백질 역시도 기능성 소재로서의 가치가 인정된다.
It is known that food proteins can denature in the body during digestion or during fermentation and aging process during food production, and can exhibit various physiological activities in vivo (Moller et al., 2008). Therefore, proteins that have undergone chemical and physical denaturation are recognized as functional materials.

난백 단백질의 물리, 화학적 변성을 통한 기능성 소재개발에 대해서 대한민국 공개특허 제 10-2011-40018에서는 난백에 존재하는 단백질 오버트랜스페린 가수분해 물의 혈압을 낮추는 활성에 대해 개시하였고, 대한민국 공개특허 제 10-2004-48650호에서는 난백 단백질의 가수 분해물을 함유한 조미료 제조방법에 대해 개시하였다. 또 대한민국 공개특허 제 10-2002-67203호에서는 계란 알끈으로부터 분리한 혈전용해 펩타이드 제조 방법에 대해서 개시하였다.
Korean Patent Laid-Open No. 10-2011-40018 discloses the activity of lowering the blood pressure of the protein over-transferrin hydrolyzate present in the egg white for the development of a functional material through physical and chemical modification of the egg white protein. Korean Patent Laid- -48650 discloses a process for preparing seasonings containing a hydrolyzate of egg white protein. Korean Patent Laid-Open No. 10-2002-67203 discloses a method for preparing a thrombolytic peptide separated from egg yolk.

따라서, 본 발명의 목적은 난백 단백질인 오버트랜스페린을 TECP를 이용한 가수분해 반응을 통하여 유용한 가수분해물을 유도하는 데 있다.Accordingly, it is an object of the present invention to derive a useful hydrolyzate from an egg white protein, overtransferrin, through a hydrolysis reaction using TECP.

본 발명의 다른 목적은, 상기의 항산화 기능이 증대된 기능성 오버트랜스페린 가수분해물을 제공하는 데 있다. Another object of the present invention is to provide a functional overtransferrin hydrolyzate having the above-mentioned antioxidant function.

본 발명의 상기 목적은 순도가 높은 오버트랜스페린(순도: 98%)에 Tris(2-carboxyethyl)phosphine hydrochloride (TCEP)를 처리하여 오버트랜스페린을 가수분해하는 단계와; 상기 가수분해물을 투석막으로 투석하여 TCEP를 제거하는 단계와; 상기 TCEP가 제거된 오버트랜스페린 가수분해물을 원심분리하여 상층액을 얻고 그 상층액을 동결 건조하는 단계와; 상기 동결건조 시료의 지질과산화 억제 활성을 측정하는 단계를 통하여 달성하였다.The above object of the present invention is achieved by a method for purifying an overtransferrin, comprising: hydrolyzing an over-transferrin by treating Tris (2-carboxyethyl) phosphine hydrochloride (TCEP) to an over-transferrin (purity: 98%) having high purity; Dialyzing the hydrolyzate to a dialysis membrane to remove TCEP; Centrifuging the TCEP-removed over-transferrin hydrolyzate to obtain a supernatant, and lyophilizing the supernatant; And measuring lipid peroxidation inhibiting activity of the lyophilized sample.

본 발명은 난백 단백질인 오버트랜스페린을 TECP를 이용한 가수분해 반응을 통하여 가수분해물을 획득하고, 상기 항산화 기능이 증대된 오버트랜스페린의 가수분해물을 제공하는 효과가 있다. The present invention provides a hydrolyzate of over-transferrin, which is an egg white protein, through hydrolysis using TECP, and provides a hydrolyzate of over-transferrin with enhanced antioxidant function.

도 1은 오버트랜스페린를 Tris(2-carboxyethyl)phosphine hydrochloride (TCEP)이용한 가수분해물 제조를 위한 모식도이다.
도 2는 본 발명 TCEP를 통하여 가수분해된 오버트랜스페린의 TBA 실험법을 이용한 지질 과산화 억제활성에 관한 그래프이다; 대조구 (◆),오버트랜스페린 2 mg/mL (▲), 본 발명 가수분해된 ovotrasferrin 2 mg/mL (●), 본 발명 가수분해된 ovotrasferrin 1 mg/mL (△), 본 발명 가수분해된 ovotrasferrin 0.5 mg/mL (○).
도 3은 본 발명 TCEP를 통하여 가수분해된 오버트랜스페린의 FTC 실험법을 이용한 지질 과산화 억제활성에 관한 그래프이다; (◆),오버트랜스페린 2 mg/mL (▲), 본 발명 가수분해된 ovotrasferrin 2 mg/mL (●), 본 발명 가수분해된 ovotrasferrin 1 mg/mL (△), 본 발명 가수분해된 ovotrasferrin 0.5 mg/mL (○).
BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a schematic diagram for preparing a hydrolyzate using over-transferrin with Tris (2-carboxyethyl) phosphine hydrochloride (TCEP).
FIG. 2 is a graph showing inhibitory activity against lipid peroxidation by TBA assay of over-transferrin hydrolyzed through TCEP of the present invention; The ovotrasferrin hydrolyzed ovotrasferrin of the present invention (mg), the ovotrasferrin hydrolyzate of the present invention (mg), the hydrolyzed ovotrasferrin of the present invention (mg), the hydrolyzed ovotrasferrin 0.5 of the present invention mg / mL (O).
Figure 3 is a graph showing the results of the FTC assay of the over-transferrin hydrolyzed through the TCEP of the present invention Lt; RTI ID = 0.0 > lipid < / RTI > (O), ovotrasferrin (mg) of the present invention hydrolyzed, ovotrasferrin of the present invention (mg), ovotrasferrin of the present invention (mg) of 2 mg / / mL (O).

본 발명에서는 Tris(2-carboxyethyl)phosphine Hydrochloride (TCEP)을 이용해서 순수한 오버트랜스페린 단백질을 가수분해하여 항산화 활성이 우수한 기능성 펩타이드를 개발하고자 하였다.In the present invention, a functional peptide having excellent antioxidant activity was developed by hydrolyzing pure overtransferrin protein using Tris (2-carboxyethyl) phosphine Hydrochloride (TCEP).

본 발명 오바트랜스페린 가수분해물은 식품조성물 첨가하여 사용할 수 있다. 상기 본 발명 오바트랜스페린 가수분해물은 5 내지 20 % 의 농축액의 형태 또는 분말형태로 식품조성물에 첨가하는 것이 바람직하다.The overtransferrin hydrolyzate of the present invention can be used by adding a food composition. The above-mentioned overtransferrin hydrolyzate of the present invention is preferably added to the food composition in the form of a concentrate of 5 to 20% or powder.

본 발명 오바트랜스페린 가수분해물을 첨가하여 사용할 수 있는 기능성 식품 조성물은 건강을 위한 식품, 음료, 또는 음료첨가제 등이며, 상기 기능성 조성물은 식품 100 중량%에 대하여 0.1 중량% 내지 20 중량%로 물에 혼합하여 항산화 효과를 목적으로 한 기능성 음료 또는 상기 본 발명 오바트랜스페린 가수분해물을 건조 분말화하여 충진한 연질 또는 경질 캡슐제의 형태로 이용하는 것이 바람직하다.The functional food composition which can be used by adding the overtransferrin hydrolyzate of the present invention is a food, beverage, or beverage additive for health and the like. The functional composition is mixed with 0.1 to 20 wt% It is preferable to use a functional beverage for the purpose of antioxidative effect or a soft or hard capsule filled with the overtransferrin hydrolyzate of the present invention as a dry powder.

본 발명 오바트랜스페린 가수분해물을 유효성분으로 포함하는 조성물은 항산화 효과를 위한 보조식품 등에도 다양하게 이용될 수 있다. 본 조성물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 식품류, 껌, 캔디, 과자류, 차, 비타민 복합제, 건강기능 식품류 등이 있다.The composition comprising the overtransferrin hydrolyzate of the present invention as an active ingredient can be used variously for an auxiliary food for antioxidative effect. Foods to which the present composition can be added include, for example, various foods, gums, candies, confectionery, tea, vitamin complexes, and health functional foods.

본 발명 오바트랜스페린 가수분해물이 함유된 음료 조성물은 지시된 비율로 필수 성분으로서 특별한 제한은 없으나 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스, 올리고당 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진 등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다.The beverage composition containing the overtransferrin hydrolyzate of the present invention is not particularly limited as an essential ingredient in the indicated ratio, but may contain various flavors or natural carbohydrates as an additional ingredient such as ordinary beverages. Examples of such natural carbohydrates include monosaccharides such as glucose, fructose, and the like; Disaccharides such as maltose, sucrose, oligosaccharides and the like; And polysaccharides such as dextrin, cyclodextrin and the like, and sugar alcohols such as xylitol, sorbitol, and erythritol. Natural flavors (tau martin, stevia extracts (e.g., rebaudioside A, glycyrrhizin, etc.) and synthetic flavors (saccharin, aspartame, etc.) can be advantageously used as flavors other than those described above .

상기 외에 본 발명 오바트랜스페린 가수분해물은 여러가지 영양제, 비타민류, 광물(전해질), 식이성분, 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명 오바트랜스페린 가수분해물은 천연 과일 쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 본 발명은 요쿠르트 등의 유산균 제제 음료 또는 페이스트 등의 혼합제로 사용할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 바람직하게는 본 발명 오바트랜스페린 가수분해물은 100 중량% 당 0.01 내지 약 20 중량부%의 범위에서 선택되는 것이 바람직하다.
In addition to the above, the overtransferrin hydrolyzate of the present invention can be used as a flavoring agent such as various nutrients, vitamins, minerals (electrolytes), dietary components, synthetic flavors and natural flavors, colorants and intermediates such as cheese, Salts of alginic acid and its salts, organic acids, protective colloid thickening agents, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated beverages and the like. In addition, the overtransferrin hydrolyzate of the present invention may contain natural fruit juice and pulp for the production of fruit juice drinks and vegetable drinks. The present invention can be used as a mixer such as a lactic acid bacterium preparation drink or paste such as yogurt. These components may be used independently or in combination. Preferably, the overtransferrin hydrolyzate of the present invention is selected from the range of 0.01 to about 20 parts by weight per 100% by weight.

이하, 본 발명의 구체적인 내용을 바람직한 실시예 및 실험예를 통하여 상세히 설명하나, 하기 실시예 및 실험예에 의해 본 발명의 권리 범위가 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to preferred embodiments and experimental examples. However, the scope of the present invention is not limited by the following examples and experimental examples.

<실시예 1> 본 발명 오버트랜스페린의 가수분해 펩타이드 제조<Example 1> Production of hydrolysis peptide of over-transferrin

오버트랜스페린(순도: 98%)은 미국의 아이오와주립대학교 (Iowa State University, Ames) 안동욱 교수로부터 제공받아 사용하였다. 상기 오버트랜스페린의 환원을 위해서 사용된 Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) 시약은 Tokyo Chemical Industry Co., Ltd.(Tokyo, Japan)에서 구입하여 사용하였다. Over-transferrin (purity: 98%) was supplied by Professor Andong Wook of Iowa State University, Ames, USA. Tris (2-carboxyethyl) phosphine hydrochloride (TCEP) reagent used for the reduction of the overtransferrin was purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan).

오버트랜스페린의 가수분해물은 다음과 같은 방법으로 제조하였다(Ibrahim et al., 2009). 0.2 mM TCEP를 pH 4.0의 20 mM citrate-phosphate buffer에 오버트랜스페린과 함께 녹여 0.1% 소디움 도데실 설페이트(SDS)를 처리하고 37°C에서 6시간 반응시킨 후, 암모늄 수용액을 이용하여 pH를 7.0으로 조절하였다. 이를 cut off size 3,500 Da의 투석막으로 48시간 투석하여 TCEP를 제거해 주었다. 이를 3,000 rpm, 20 분간에서 원심분리(Combi-514R, Hanil, Gyunggi-do, Korea)하여 상층액을 동결 건조하여 실험에 사용하였다.
Hydrolysates of overtransferrin were prepared as follows (Ibrahim et al., 2009). 0.2 mM TCEP was dissolved in 20 mM citrate-phosphate buffer (pH 4.0) with overtransferrin, treated with 0.1% sodium dodecyl sulfate (SDS) and reacted at 37 ° C for 6 hours. Respectively. TCEP was removed by dialysis with a cut-off size of 3,500 Da for 48 hours. The supernatant was centrifuged at 3,000 rpm for 20 minutes (Combi-514R, Hanil, Gyunggi-do, Korea) and the supernatant was lyophilized and used in the experiment.

<실시예 2> 본 발명 오버트랜스페린 가수분해물의 항산화능 측정<Example 2> Measurement of antioxidant activity of the over-transferrin hydrolyzate of the present invention

본 발명 실험예에서 사용한 시약은 ammonium thiocyanate 와 Iron (Ⅱ) chloride tetrahydrate는 Samchun Pure Chemical Co., Ltd. (Gyunggi-do, Korea)에서 구입하였고, ascorbic acd, butylated hydroxyanisole는 Sigma Chemical Co., Ltd. (St. Louis, MO, USA)에서 구입하여 사용하였다.
Ammonium thiocyanate and Iron (II) chloride tetrahydrate were used in the experimental examples of the present invention as described in Samchun Pure Chemical Co., Ltd. (Gyunggi-do, Korea), ascorbic acid and butylated hydroxyanisole were purchased from Sigma Chemical Co., Ltd. (St. Louis, MO, USA).

실험예 1 Thiobarbituric acid(TBA) 방법에 의한 본 발명 오버트랜스페린 가수분해물의 지질과산화 억제 활성 측정EXPERIMENTAL EXAMPLE 1 Measurement of lipid peroxidation inhibitory activity of the present invention over-transferrin hydrolyzate by Thiobarbituric acid (TBA) method

Thiobarbituric acid를 이용한 지질과산화 측정은 Osawa. et al. (1981)과 Kim et al. (2011)의 방법을 수정하여 측정하였다. Measurement of lipid peroxidation using thiobarbituric acid. et al. (1981) and Kim et al. (2011) was modified and measured.

Tris-maleate buffer (pH 6.8) 100 mL에 corn oil 1.0 g, Tween 20 0.1 mL 을 첨가하여 균질기(Ika ultra-turrax T25, Staufen, Germany)로 4분간 균질하여 oil emulsion stock 용액을 만들었다. 이 용액 8 mL에 0.2 % ascorbic acid, 200 ppm FeCl3을 각각 0.5 mL씩 넣어주고, 가수분해되지 않은 오버트랜스페린 및 오버트랜스페린의 가수분해물을 농도 별로 1 mL씩 첨가하여 37°C에서 반응하면서 일정 간격으로 흡광도를 측정하였다. 먼저 농도 별 시료 용액 1 mL에 Thiobarbituric acid/trichloroacetic acid(20 mM TBA/15% TCA, w/v) 용액 2 mL, 10% butylated hydroxyanisole solution(10% BHA in 90% ethanol) 50 μL을 첨가하여 90°C에서 15분간 시료가 발색 되도록 하였다. 이를 흐르는 물에 냉각시킨 후 원심분리(3,000 rpm, 15 min)하여 상층액을 532 nm(Optizen 2120 UV plus, Mecasys, Seoul, Korea)에서 흡광도로 측정하였다.
1.0 mL of corn oil and 0.1 mL of Tween 20 were added to 100 mL of Tris-maleate buffer (pH 6.8) and homogenized for 4 minutes with a homogenizer (Ika ultra-turrax T25, Staufen, Germany) to form an oil emulsion stock solution. Add 0.5 mL of 0.2% ascorbic acid and 200 ppm FeCl 3 to 8 mL of this solution, add 1 mL of the hydrolyzate of non-hydrolyzed overtransferrin and overtransferrin to each concentration, react at 37 ° C, Absorbance was measured. First, add 2 mL of Thiobarbituric acid / trichloroacetic acid (20 mM TBA / 15% TCA, w / v) solution and 50 μL of 10% butylated hydroxyanisole solution (10% BHA in 90% ethanol) The samples were allowed to develop for 15 minutes at &lt; RTI ID = 0.0 &gt; After cooling in running water, the supernatant was measured by absorbance at 532 nm (Optizen 2120 UV plus, Mecasys, Seoul, Korea) by centrifugation (3,000 rpm, 15 min).

본 발명의 지질의 과산화 정도를 측정하기 위한 알데히드류 측정법의 하나인 TBA 분석법은 다가 불포화지방산의 산화로 2차적으로 생성된 carbonyl compounds 중 대표적인 malonaldehyde와 TBA가 반응한 결과로 나타나는 붉은 색의 정도를 비색 정량하여 유지의 산패 정도를 측정하는 방법이다. The TBA assay, which is one of the methods for measuring the degree of peroxidation of lipid of the present invention, is a method for measuring the degree of red color which is a result of reaction of TBA with malonaldehyde, which is a secondary carbonyl compound produced by oxidation of polyunsaturated fatty acid And measuring the degree of rancidity of the retention.

본 발명에서는 계란 난백에서 추출한 오버트랜스페린 및 본 발명 오버트랜스페린 가수분해물의 성분에 대한 항산화 효과는 oil emulsion 상에서 대조구와 항산화능을 흡광도 값을 비교하였고 상기 흡광도 측정 결과는 도 2에 정리하였다.In the present invention, the antioxidant effect of the over-transferrin extracted from egg white and the over-transferrin hydrolyzate of the present invention was compared with that of control and antioxidant activity in the oil emulsion, and the results of the absorbance measurement were summarized in FIG.

도 2에 나타난 바와 같이 시료대신 증류수를 첨가한 대조구에 비하여 본 발명 오버트랜스페린 가수분해물은 낮은 TBA값을 나타내었다. 반응 24시간의 경우 대조군의 경우 흡광도 값이 0.419로 나타났으며, 오버트랜스페린(2 mg/mL)의 경우 0.315로 붉은색을 나타내었다. 반면, 본 발명 오버트랜스페린 가수분해물의 경우 1, 2 mg/mL의 농도에서 각각 0.024, 0.039로 낮은 흡광도를 관찰하였다. 상기 결과는 높은 지방 산패 억제능을 의미한다.As shown in FIG. 2, the over-transferrin hydrolyzate of the present invention showed a low TBA value as compared with the control to which distilled water was added instead of the sample. The absorbance value of the control group was 0.419 for the 24 hour reaction and 0.315 for the overtransferrin (2 mg / mL). On the other hand, in the case of the over-transferrin hydrolyzate of the present invention, low absorbance was observed at 0.024 and 0.039 at 1 and 2 mg / mL, respectively. The above results indicate a high inhibition of lipid peroxidation.

반응 48시간까지 대조군과 오버트랜스페린의 경우 유지 산패가 계속적으로 일어나 최종 0.600 이상의 흡광도 값을 나타내었지만 도 2에 나타난 것처럼 흡광도의 변화가 그리 크지 않았다. 본 발명 오버트랜스페린 가수분해물의 경우 1, 2 mg/mL 농도에서 0.3 정도의 흡광도 값을 나타내었으며, 이는 본 발명 오버트랜스페린의 가수분해물에 의한 약 46~48%의 지방 산패 억제 효과를 나타냈다.
In the case of the control and the overtransferrin until 48 hours of the reaction, persistent rancidity occurred and the absorbance value was 0.600 or more at the end, but the change of the absorbance was not significant as shown in Fig. In the case of the over-transferrin hydrolyzate according to the present invention, the absorbance value was 0.3 at a concentration of 1 or 2 mg / mL, indicating that the hydrolyzate of the present invention over-transferrin inhibited lipolysis by about 46-48%.

실험예 2 Ferric thiocyanate (FTC) 방법에 의한 본 발명 오버트랜스페린 가수분해물에 의한 지질과산화 억제 활성 측정EXPERIMENTAL EXAMPLE 2 Measurement of inhibitory activity of lipid peroxidation by the over-transferrin hydrolyzate of the present invention by ferric thiocyanate (FTC) method

Ferric thiocyanate에 의한 지질과산화 측정은 Kim 등(2004)의 방법을 수정하여 측정하였다. 농도 별 TCEP 이용 가수분해물 0.1 mL에 40 mM phosphate buffer (pH 7.0) 0.4 mL, linoleic acid 0.2 mL(25 mg/mL in ethanol), 증류수 0.2 mL을 혼합하여 stock solution을 만든 후 이를 37°C에서 배양하면서 24시간 마다 흡광도를 측정하였다. 먼저 stock solution 0.1 mL에 70% ethanol 4 mL, 20 mM ferrous chloride, 30% ammonium thiocyanate 0.1 mL씩을 가하여 3분간 반응 후 500 nm에서 흡광도를 측정하였다.
Measurement of lipid peroxidation by ferric thiocyanate was performed by modifying the method of Kim et al. (2004). To the 0.1 mL of TCEP hydrolysates by concentration 0.4 mL of 40 mM phosphate buffer (pH 7.0), 0.2 mL of linoleic acid (25 mg / mL in ethanol), and 0.2 mL of distilled water were mixed to prepare a stock solution, which was incubated at 37 ° C And the absorbance was measured every 24 hours. First, 4 mL of 70% ethanol, 20 mL ferrous chloride, and 0.1 mL of 30% ammonium thiocyanate were added to 0.1 mL stock solution, and the absorbance was measured at 500 nm for 3 minutes.

Ferric thiocyanate (FTC)법은 지질 산화 초기에 생성되는 과산화물의 양을 측정하여 산화의 정도를 측정하는 것으로(Haraguchi et al., 1992), 형성된 과산화물은 ferrous chloride와 반응하여 붉은색의 ferric chloride 색소를 생성한다(Jeong et al., 2007). 본 발명에서는 비교구로 사용 중인 오버트랜스페린 및 TCEP 이용 가수분해물의 농도를 0.5, 1, 그리고 2 mg/mL로 하여 linoleic acid와 반응시킨 후 24시간 간격으로 흡광도를 측정하여 과산화물 생성량을 조사하여 도 3에 나타냈다. 시료를 첨가하지 않고 용매인 증류수만으로 측정한 대조구(control)의 경우 반응 5일째에 지질 산화에 의한 과산화물의 생성으로 흡광도가 0.825로 높게 측정되었으나, 오버트랜스페린(2 mg/mL)의 경우 0.608, 본 발명 오버트랜스페린의 가수분해물 처리에 의한 흡광도의 경우에는 각각 0.130, 0.164, 0.161로 낮은 수준의 지질 산화가 진행되었음을 알 수 있었다. 반응 5일째에 측정된 대조구의 흡광도 값을 기준으로 하여 각각 처리구의 지질 산화 억제율을 산출한 결과, 오버트랜스페린은 26%로 낮은 산화 억제율을 보였지만 본 발명 오버트랜스페린의 가수분해물의 경우 80% 이상의 산화 억제율을 보였다.
Ferric thiocyanate (FTC) method measures the degree of oxidation by measuring the amount of peroxide produced at the beginning of lipid oxidation (Haraguchi et al., 1992). The peroxide formed reacts with ferrous chloride to produce a red ferric chloride dye (Jeong et al., 2007). In the present invention, peroxidase production was measured by measuring absorbance at 24 hour intervals after reacting with linoleic acid at concentrations of 0.5, 1, and 2 mg / mL of the over-transferrin and TCEP hydrolyzate used as comparators, . In the case of the control without the addition of the sample, the absorbance was measured as 0.825 due to the production of peroxide by lipid oxidation on the 5th day of the reaction but 0.608 in the case of overtransferrin (2 mg / mL) In the case of the absorbance of the hydrolysates of the invented overtransferrin, 0.130, 0.164 and 0.161, respectively, showed low levels of lipid oxidation. Based on the absorbance value of the control measured on the 5th day of the reaction, the inhibition rate of lipid oxidation of the treatment groups was calculated. As a result, overtransferrin showed a low oxidation inhibition rate of 26%, but in the case of the hydrolysates of overtransferrin of the present invention, Respectively.

이상에서 설명한 바와 같이, 본 발명은 오버트랜스페린의 가수분해물을 천연 항산화제로 제공하는 효과가 있을 뿐 아니라 양계산업 및 식품산업에 매우 유용한 발명이다.INDUSTRIAL APPLICABILITY As described above, the present invention not only provides a hydrolyzate of overtransferrin as a natural antioxidant, but also is a very useful invention for the poultry industry and the food industry.

Claims (1)

오버트랜스페린(Ovotransferrin)을 tris(2-carboxyethyl)phosphine hydrochloride(TCEP)와 함께 pH 4.0의 citrate-phosphate 버퍼에 녹여 37℃에서 6시간 반응시켜 오버트랜스페린을 환원 단계와; 상기에서 얻은 가수분해물로부터 TCEP를 제거하는 단계와; 상기 TCEP가 제거된 가수분해물을 원심분리하여 오버트랜스페린의 가수분해물의 정제방법에 있어서,

상기 오버트랜스페린 환원 단계에서 0.1% 소디움 도데실 설페이트(SDS)를 첨가하여 반응시킨 다음 암모니움 수용액으로 pH 7.0으로 조절하는 단계와; Cut off size 3.5 KDa의 투석막으로 48시간 투석하여 TCEP를 제거하는 단계를 더 포함하여 수행되는 것이 특징인 과산화 지질억제 활성이 증대된 오버트랜스페린 가수분해물의 정제방법.
Overtransferrin was dissolved in citrate-phosphate buffer (pH 4.0) with tris (2-carboxyethyl) phosphine hydrochloride (TCEP) and reacted at 37 ° C for 6 hours to reduce the overtransferrin; Removing TCEP from the hydrolyzate obtained above; In the method for purifying the hydrolyzate of the overtransferrin by centrifuging the TCEP-removed hydrolyzate,

Adding 0.1% sodium dodecyl sulfate (SDS) in the overtransferrin reducing step, and then adjusting the pH to 7.0 with an aqueous ammonia solution; And removing the TCEP by dialyzing the dialyzed membrane at a cut-off size of 3.5 KDa for 48 hours. The method for purifying an overtransferrin hydrolyzate having increased lipid peroxide inhibiting activity.
KR1020150010809A 2015-01-22 2015-01-22 Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof KR101631657B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020150010809A KR101631657B1 (en) 2015-01-22 2015-01-22 Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150010809A KR101631657B1 (en) 2015-01-22 2015-01-22 Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020120039672A Division KR20130117033A (en) 2012-04-17 2012-04-17 Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof

Publications (2)

Publication Number Publication Date
KR20150024362A KR20150024362A (en) 2015-03-06
KR101631657B1 true KR101631657B1 (en) 2016-06-20

Family

ID=53021008

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020150010809A KR101631657B1 (en) 2015-01-22 2015-01-22 Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof

Country Status (1)

Country Link
KR (1) KR101631657B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190060256A (en) 2017-11-24 2019-06-03 중부대학교 산학협력단 A composition comprising peptide extracts of Yeonsan Ogye-egg and method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Food Sci. Biotechnol. 12(3): 224-227(2003).
HISHAM R. IBRAHIM 외 1명, ‘Novel Anticancer Activity of the Autocleaved Ovotransferrin against Human Colon and Breast Cancer Cells’, 농식품화학회지 제57권, 11383-11390쪽, 2009년.*
J. Agric. Food Chem. 57: 11383-11390 (2009).
SHENGWEN SHEN 외 4명, ‘Identification of novel antioxidative peptides derived from a thermolytic hydrolysate of ovotransferrin by LC-MS/MS’, 농식품화학회지 제58권, 7664-7672쪽, 2010년.*

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190060256A (en) 2017-11-24 2019-06-03 중부대학교 산학협력단 A composition comprising peptide extracts of Yeonsan Ogye-egg and method thereof

Also Published As

Publication number Publication date
KR20150024362A (en) 2015-03-06

Similar Documents

Publication Publication Date Title
US7780873B2 (en) Bioactive complexes compositions and methods of use thereof
Pozo-Bayón et al. Wine features related to safety and consumer health: an integrated perspective
US8628690B2 (en) Nanoemulsion compositions and methods of use thereof
JP5493189B2 (en) Casein complex
JP5136796B2 (en) Liquid oral composition
TWI656885B (en) Aqueous liquid composition containing collagen
JP2007526918A (en) Antioxidant composition and method of use thereof
JP2010222287A (en) Liquid composition for oral administration
KR20100108557A (en) Liver function-protecting agent
US20030004211A1 (en) Carbohydrate modifying agent and drinks containing the modifying agent
KR101631657B1 (en) Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof
AU2002305703A1 (en) Carbohydrate modifying agent and drinks containing the modifying agent
JP5248109B2 (en) Method for preventing off-flavors in beverage compositions
JP2007097465A (en) Peptide-containing food and drink reduced in bitter taste and astringency, and method for producing the same
JP6552097B2 (en) Bitterness improving agent for food and drink, method for improving bitterness for food and drink, and composition for food and drink
JP2009062301A (en) Essence of morinda citrifolia l. and use thereof
KR102026781B1 (en) Method of manufacturing spirulina having increased selenium and use thereof
KR102297123B1 (en) Method for Producing Hydrolysate of Egg Yolk Protein and Composition for Antioxidant Using The Same
KR20130117033A (en) Ovotrasferrin hydrolysate having with antioxidant activity and method for preparation thereof
TWI676485B (en) Composition containing collagen peptide
KR102025318B1 (en) Method for producing yeast extract with enhanced color, odor and taste
Saranya Chapter-7 Phytonutrients Enrichment in Functional Dairy Products: A Review
JP2004143127A (en) Pathogenic cysteine protease activity inhibitor
WO2015112826A1 (en) Method of preparing a hydrolysed protein with increased aqueous solubility and nutritional composition comprising a hydrolysed protein
US20220218580A1 (en) Flavor or aroma deterioration inhibitor containing theanaphthoquinone and analogues thereof as active ingredient

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20190520

Year of fee payment: 4